Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OCTRU have now given Green Light approval for The World Hip Trauma Evaluation (WHiTE) Platform and its first embedded randomised comparison WHiTE 11 FRUITI: Fix or Replace Undisplaced Intracapsular fractures Trial of Interventions, which is now open to recruitment. The WHiTE Platform is a clinical trials framework designed to efficiently deliver multiple randomised comparisons of interventions for fragility hip fracture in those aged 60 and over. The FRUITI comparison aims to determine whether there is a difference in health-related quality of life at four months after surgery in patients with undisplaced intracapsular fractures treated with internal fixation or hip replacement.

 Follow on Twitter! @WHiTEPlatform  @WHiTE11FRUITI